Treatment of SKIV2L-deficient mice with the mTOR inhibitor rapamycin relieves their skin inflammation, suggesting a possible therapeutic strategy for SKIV2L-associated trichohepatoenteric syndrome.73,74 These studies indicate a context-dependent immune regulation function of SKIV2L. The gene discussed is SKIC2; the disease is trichohepatoenteric syndrome.